0001415889-23-011410.txt : 20230724
0001415889-23-011410.hdr.sgml : 20230724
20230724163008
ACCESSION NUMBER: 0001415889-23-011410
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230720
FILED AS OF DATE: 20230724
DATE AS OF CHANGE: 20230724
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MAHON PAUL A
CENTRAL INDEX KEY: 0001231589
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26301
FILM NUMBER: 231105348
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp
CENTRAL INDEX KEY: 0001082554
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 521984749
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1000 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
BUSINESS PHONE: 3016089292
MAIL ADDRESS:
STREET 1: 1000 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
FORMER COMPANY:
FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP
DATE OF NAME CHANGE: 19990324
4
1
form4-07242023_040702.xml
X0508
4
2023-07-20
0001082554
UNITED THERAPEUTICS Corp
UTHR
0001231589
MAHON PAUL A
C/O UNITED THERAPEUTICS CORPORATION
1000 SPRING STREET
SILVER SPRING
MD
20910
false
true
false
false
EVP & GENERAL COUNSEL
0
Common Stock
2023-07-20
4
M
0
2500
120.26
A
39099
D
Common Stock
2023-07-20
4
S
0
2500
243.87
D
36599
D
Stock Options
120.26
2023-07-20
4
M
0
2500
0
D
2017-03-15
2026-03-15
Common Stock
2500
0
D
This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
/s/ John S. Hess, Jr. under Power of Attorney
2023-07-24